Related Experiment Video
Updated: May 7, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Atherectomy Plus Balloon Angioplasty for Femoropopliteal Disease Compared to Balloon Angioplasty Alone: A Systematic
Waiel Abusnina1, Ahmad Al-Abdouh2, Qais Radaideh1
1Division of Cardiovascular Diseases, Creighton University School of Medicine, Omaha, Nebraska.
Insights
Atherectomy plus balloon angioplasty (ABA) may reduce target lesion revascularization and bailout stenting for femoropopliteal disease, but evidence from randomized trials is limited. Further research is needed to confirm these findings.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Medical Device Technology
Background:
- Femoropopliteal disease treatment is evolving.
- The efficacy of atherectomy combined with balloon angioplasty (BA) is debated.
- A meta-analysis was conducted to compare atherectomy plus balloon angioplasty (ABA) versus BA alone.
Purpose of the Study:
- To compare the clinical efficacy and safety of atherectomy plus balloon angioplasty (ABA) versus balloon angioplasty (BA) alone.
- To evaluate outcomes in patients with femoropopliteal disease.
Main Methods:
- A systematic search of PubMed, Cochrane, EMBASE, and ClinicalTrials.gov was performed.
- Nine studies (4 randomized, 5 retrospective) with 699 patients were included.
- Random-effects models were used to calculate risk ratios for target lesion revascularization (TLR), primary patency, and bailout stenting.
Main Results:
- Atherectomy plus balloon angioplasty (ABA) showed a significant decrease in TLR and bailout stenting in nonrandomized studies.
- No significant difference in TLR was observed when including only randomized trials.
- Primary patency did not differ significantly between the ABA and BA alone groups.
Conclusions:
- Randomized trial data indicate no difference in TLR or primary patency between ABA and BA alone.
- Observational studies suggest ABA may reduce TLR and bailout stenting.
- Further research is necessary to clarify the role of ABA in femoropopliteal disease.
Background:
The role of atherectomy in treating femoropopliteal disease has been evolving rapidly. However, the clinical efficacy and safety of adjunctive atherectomy to percutaneous balloon angioplasty (BA) (plain balloon and drug-coated BA) remains controversial. We sought to perform a meta-analysis comparing atherectomy plus balloon angioplasty (ABA) versus BA alone in treating femoropopliteal disease.
Methods:
We searched PubMed, Cochrane Central Register of Clinical Trials, EMBASE, and ClinicalTrials.gov (from inception through January 10, 2022) for studies comparing ABA versus BA for femoropopliteal disease. We used a random-effects model to calculate risk ratio (RR) with 95% CIs. Target lesion revascularization (TLR), primary patency, and bailout stenting were the primary outcomes.
Results:
Nine studies with 699 patients were included (4 randomized and 5 retrospective studies). Compared to BA alone, the ABA group showed a significant decrease in TLR driven by nonrandomized studies (RR 0.59; 95% CI, 0.40-0.85; P = .005) and bailout stenting (RR, 0.32; 95% CI, 0.21-0.48; P < .0001). There was no significant difference in TLR when the analysis was performed including only randomized trials. There was no significant difference in the primary patency between the 2 groups (RR, 1.04; 95% CI, 0.95-1.14; P = .37).
Conclusions:
Data from randomized trials suggest that compared with BA alone, the combination of atherectomy and BA showed no difference in TLR or primary patency. In observational studies, TLR and bailout stenting were reduced in ABA group but there was no difference in primary patency. Further studies are needed to investigate the clinical outcomes of atherectomy combined with BA in femoropopliteal lesions compared with BA alone.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care